PharmaCyte Biotech
Open
$0.82
Prev. Close
$0.82
High
$0.83
Low
$0.82
Market Snapshot
$8.39M
-0.9
0.53
2
PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. The company is headquartered in Las Vegas, Nevada and currently employs 2 full-time employees. The company went IPO on 2003-09-11. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including locally advanced, inoperable, non-metastatic pancreatic cancer (LAPC) will be developed. The Cell-in-a-Box encapsulation technology potentially enables genetically engineered live human cells to be used as a means to produce various biologically active molecules. The technology is intended to result in the formation of pinhead-sized cellulose-based porous capsules in which genetically modified live human cells can be encapsulated and maintained. In a laboratory setting, this proprietary live cell encapsulation technology has been shown to create a micro-environment in which encapsulated cells survive and flourish.
PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. The company is headquartered in Las Vegas, Nevada and currently employs 2 full-time employees. The company went IPO on 2003-09-11. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including locally advanced, inoperable, non-metastatic pancreatic cancer (LAPC) will be developed. The Cell-in-a-Box encapsulation technology potentially enables genetically engineered live human cells to be used as a means to produce various biologically active molecules. The technology is intended to result in the formation of pinhead-sized cellulose-based porous capsules in which genetically modified live human cells can be encapsulated and maintained. In a laboratory setting, this proprietary live cell encapsulation technology has been shown to create a micro-environment in which encapsulated cells survive and flourish.
Recently from Cashu
PharmaCyte Biotech Advances Innovative Cell Therapy for Cancer and Diabetes Management
PharmaCyte Biotech Advances Cell Therapy Initiatives PharmaCyte Biotech, a company specializing in cell-based therapies for cancer and diabetes, is making significant strides in its clinical developme…
PharmaCyte Biotech Innovates Cancer Treatment with Cell-in-a-Box® Technology Progress
PharmaCyte Biotech Advances in Cancer Treatment Research PharmaCyte Biotech is making significant strides in its ongoing research into novel cancer treatments. The company focuses on developing therap…
PharmaCyte Biotech Reports Promising Progress in Novel Pancreatic Cancer Treatment Development
PharmaCyte Biotech Advances Its Innovative Cancer Treatment with New Data Release PharmaCyte Biotech showcases significant progress in its clinical development of a novel treatment for pancreatic canc…
PharmaCyte Biotech Advances Innovative Cancer Treatments and Clinical Trials for Pancreatic Cancer
PharmaCyte Biotech Advances Its Cancer Treatment Strategy PharmaCyte Biotech is making significant strides in its development of innovative cancer treatments, particularly through its flagship therapy…